Actions To Be Taken:
Information for Patients
Patients will be contacted by their pharmacist to ensure the return of any unused or partially used units from the above-listed batches.
- If you have not as yet been contacted, please check the batch numberof the cartridge(s) currently in your posession
- If you are in the possession of a pack from an affected batch, please return it to your pharmacy, where you will receive a replacement, unaffected pack
- If you are using NovoMix 30 Penfill with a batch number not mentioned above, or if you are using NovoMix 30 Flexpen, you can continue your treatment as usual
Please click on the link below for a letter from Novo Nordisk, intended for patients
NovoMix 30 Penfill Patient letter
Specific information for Pharmacists
All pharmacists registered in Ireland have been sent a recall letter via email on October 29th 2013, which details the steps to be taken to ensure an effective recall to pharmacy and patient level can occur. The letter is available at the below link.
NovoMix 30 Penfill Pharmacy recall letter
Information for Prescribers and other Healthcare Professionals
The relevant healthcare professionals will be sent a Direct Healthcare Professional Communication by Novo Nordisk, to inform them of the recall and to provide information which can be shared with patients, should they have concerns regarding the recall. This letter is available at the below link.
NovoMix 30 Penfill DHPC
Specific information for Wholesalers
Wholesalers which received the above-listed batches have also been sent a recall letter on October 29th 2013; a copy of which can be found at the below link.
NovoMix 30 Penfill Wholesaler letter